Postdoc position open to study the effects of alcohol/abused substances. Supported by our NIAAA T32. US citizens or permanent residents only. Individuals underrepresented in the field are encouraged to apply. Will attend CPDD and RSA in June 2024. Contact: rmartinf@scripps.edu
Postdoc position available to investigate the effects of alcohol and other abused substances. Supported by our NIH/NIAAA T32. US citizens or permanent resident status is required. Individuals underrepresented in the field are encouraged to apply. Contact: rmartinf@scripps.edu
A new Scripps Research study shows how an insomnia drug helps prevent oxycodone relapse, paving the way for new therapies. scripps.edu/news-and-events/…
Fantastic panel focusing on alcohol's effect on the CRF system outside the amygdala (!) Very cool work by Remi Martin-Fardon, @DrJRink Audrey Seasholtz and @superrsema and great moderating by @Marcus
Looking forward to chairing this symposium on CRF-alcohol interactions outside the amygdala with @superrsema at @RSAposts. Come by this Sunday at 1:20 if you can! (1/2)
Scientists in @FardonLab have shown in preclinical studies that the insomnia drug suvorexant is able to reduce prescription opioid intake and help protect against relapse in animals modeling opioid use disorder scripps.edu/news-and-events/…
In a new study by @FardonLab, the team show that the insomnia drug suvorexant, which blocks the activity of brain-cell receptors called orexin receptors, could be repurposed to help reduce voluntary alcohol intake and relapse scripps.edu/news-and-events/…@FrontiersIn
ALT A schematic showing alcohol bottles and glasses in the shape of a person's head